Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD

References

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). APA Publications; 5 22 2013.
   Google Scholar
• DanielsonML, BitskoRH, GhandourRM, HolbrookJR, KoganMD, BlumbergSJ. Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents. J Clin Child Adolesc Psychiatry. 2018;47(2):199–212. doi:10.1080/15374416.2017.1417860
   PubMed Web of Science ®Google Scholar
• BarkleyRA, FischerM, SmallishL, FletcherK. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002;111(2):279–289. doi:10.1037/0021-843X.111.2.27912003449
   PubMed Web of Science ®Google Scholar
• LaraC, FayyadJ, DeGraafR, et al. Childhood predictors of adult attention-deficit/ hyperactivity disorder: results from the World Health Organization World mental health survey initiative. Biol Psychiatry. 2009;65(1):46–54. doi:10.1016/j.biopsych.2008.10.00519006789
   PubMed Web of Science ®Google Scholar
• KesslerRC, AdlerL, BarkleyR, et al. The prevalence and correlates of adult ADHD in the united states: results from the national comorbidity survey replication. Am J Psychiatry. 2006;163(4):716–723. doi:10.1176/ajp.2006.163.4.71616585449
   PubMed Web of Science ®Google Scholar
• WolraichM, BrownL, BrownRT, et al. Subcommittee on attention-deficit/hyperactivity disorder; steering committee on quality improvement and management. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007 1022. doi:10.1542/peds.2011-265422003063
   PubMed Web of Science ®Google Scholar
• PliszkaS; AACAP Working Group on Quality Issues. AACAP work group on quality issues practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921. doi:10.1097/chi.0b013e318054e72417581453
   PubMed Web of Science ®Google Scholar
• McGoughJJ. Treatment controversies in adult ADHD. Am J Psychiatry. 2016;173(10):960–966. doi:10.1176/appi.ajp.2016.1509120727690551
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services, FDA. Quality attribute considerations for chewable tablets, guidance for industry; 6 2016. Available from: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm. Accessed 1117, 2020.
   Google Scholar
• US Department of Health and Human Services, FDA. Quality attribute considerations for chewable tablets, guidance for industry; 8 2018. Available from: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm. Accessed 1117, 2020.
   Google Scholar
• PardoA, KandoJC, RaflaE, HermanBK. Single dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension. CNS Spectr. 2020;25(6):774–781. doi:10.1017/S1092852919001676.31964449
   PubMed Web of Science ®Google Scholar
• FerrinM, Ruiz-VeguillaM, Blanc-BetesM, et al. Evaluation of attitudes towards treatment in adolescents with attention deficit hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. 2012;21(7):387–401. doi:10.1007/s00787-012-0277-622714140
   PubMed Web of Science ®Google Scholar
• ZetterqvistJ, AshersonP, HalldnerL, LångströmN, LarssonH. Stimulant and non-stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006–2009. Acta Psychiatr Scand. 2013;128(1):70–77. doi:10.1111/acps.12004.22943458
   PubMed Web of Science ®Google Scholar
• GarbeE, MikolajczykRT, BanaschewskiT, et al. Drug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study. J Child Adolesc Psychopharmacol. 2012;22(6):452–458. doi:10.1089/cap.2012.002223234588
   PubMed Web of Science ®Google Scholar
• GarjiaK, LuM, SikiricaV, et al. Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder¬a systematic literature review. Neuro Dis Treat. 2014;10:1543–1569.
   PubMed Web of Science ®Google Scholar
• ShariffZB, DahmashDT, KirbyDJ, MissaghiS, Rajabi-SiahboomiA, MaidmentID. Does the formulation of oral solid dosage forms affect acceptance and adherence in older patients? A mixed methods systematic Review. J Am Med Dir Assoc. 2020;21(8):1015–1023.e8. doi:10.1016/j.jamda.2020.01.108.32224260
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Medicines optimization: the safe and effective use of medicines to enable the best possible outcomes; 2015. Available from: https://www.nice.org.uk/guidance/ng5/chapter/introduction. Accessed 1115, 2020.
   Google Scholar
• European Medicines Agency. Guidelines on pharmaceutical development of medicines for paediatric use; 8 1, 2013. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/07/WC500147002.pdf. Accessed 1112, 2020.
   Google Scholar
• JonesWJ 3rd, FrancisJJ. Softgels: consumer perceptions and market impact relative to other oral dosage forms. Adv Ther. 2000;17(5):213–221. doi:10.1007/BF0285316011186141
   PubMed Web of Science ®Google Scholar
• ReesTP, HoweI. A Randomised, single-blind, crossover comparison of the acceptability of the calcium and vitamin D3 supplements calcichew D3 Forte® and Ad Cal D3® in elderly patients. Curr Med Res Opin. 2001;16(4):245–251. doi:10.1185/03007990175012017811268708
   PubMed Web of Science ®Google Scholar
• BaguleyD, LimE, BevanA, PalletA, FaustSN. Prescribing for children - taste and palatability affect adherence to antibiotics: a review. Arch Dis Child. 2012;97(3):293–297. doi:10.1136/archdischild-2011-300909.22088684
   PubMed Web of Science ®Google Scholar
• PhillipsSC, RolanPE, PosnerJ, et al. Greater ease of swallowing of a new film-coated 800-mg dispersible acyclovir tablet compared to the standard 800-mg tablet in elderly volunteers. J Pharm Med. 1992;2:259–262.
   Google Scholar
• Turner-BowkerDM, An HaackK, KroheM, et al. Development and content validation of the Pediatric Oral Medicines Acceptability Questionnaires (P-OMAQ): patient-reported and caregiver-reported outcome measures. J Patient Rep Outcomes. 2020;4(1):80. doi:10.1186/s41687-020-00246-133000327
   PubMedGoogle Scholar